AIRSUPRA is a combination of albuterol, a beta -adrenergic agonist and budesonide, a corticosteroid,
indicated for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of
exacerbations in patients with asthma 18 years of age and older.
